Co-targeting BRAF and cyclin dependent kinases 4/6 for BRAF mutant cancers

Title
Co-targeting BRAF and cyclin dependent kinases 4/6 for BRAF mutant cancers
Authors
Keywords
BRAF V600E, Melanoma, CDK4/6 inhibitor, Abemaciclib, Cyclin D1, Resistance
Journal
PHARMACOLOGY & THERAPEUTICS
Volume 149, Issue -, Pages 139-149
Publisher
Elsevier BV
Online
2014-12-28
DOI
10.1016/j.pharmthera.2014.12.003

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now